Literature DB >> 20632953

Neuromuscular disorders in left ventricular hypertrabeculation/noncompaction.

Josef Finsterer1, Claudia Stöllberger, Giovanni Fazio.   

Abstract

Left ventricular hypertrabeculation / noncompaction (LVHT) is in the majority of the cases associated with hereditary cardiac or skeletal muscle disease or with chromosomal abnormalities. Depending on the study more than two thirds of the LVHT patients also present with a neuromuscular disorder (NMD). NMDs most frequently associated with LVHT are the Barth syndrome, mitochondrial disorders, zaspopathy, and myotonic dystrophies. NMDs only occasionally presenting with LVHT are the dystrobrevinopathy, laminopathies, dystrophinopathies, myoadenylat-deaminase deficiency, hereditary inclusion body myositis and the hereditary neuropathy CMT1A. A causal relation between NMDs and LVHT is likely, although the exact relationship and pathomechanic association remains elusive. The close pathogenetic relation is supported by the fact that the phenomenon of acquired LVHT occurs predominantly in NMDs. Consequent referral of LVHT patients to the neurologist, consequent referral of NMD patients to the cardiologist, and family investigations may help and to elucidate unsolved issues concerning the pathogenesis, course and prognosis of LVHT.

Entities:  

Mesh:

Year:  2010        PMID: 20632953     DOI: 10.2174/138161210793176437

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  7 in total

1.  Neuromuscular comorbidity, heart failure, and atrial fibrillation as prognostic factors in left ventricular hypertrabeculation/noncompaction.

Authors:  Claudia Stöllberger; Gerhard Blazek; Martin Gessner; Katharina Bichler; Christian Wegner; Josef Finsterer
Journal:  Herz       Date:  2015-05-05       Impact factor: 1.443

2.  Epilepsy and noncompaction.

Authors:  J Finsterer; S Zarrouk-Mahjoub
Journal:  Neth Heart J       Date:  2014-06       Impact factor: 2.380

3.  Toxoplasmosis or left ventricular hypertrabeculation / non-compaction.

Authors:  J Finsterer; C Stöllberger
Journal:  J Med Life       Date:  2012-09-25

4.  New clinical and molecular insights on Barth syndrome.

Authors:  Lorenzo Ferri; Maria Alice Donati; Silvia Funghini; Sabrina Malvagia; Serena Catarzi; Licia Lugli; Luca Ragni; Enrico Bertini; Frédéric M Vaz; David N Cooper; Renzo Guerrini; Amelia Morrone
Journal:  Orphanet J Rare Dis       Date:  2013-02-14       Impact factor: 4.123

Review 5.  Successful management of Barth syndrome: a systematic review highlighting the importance of a flexible and multidisciplinary approach.

Authors:  Stacey Reynolds
Journal:  J Multidiscip Healthc       Date:  2015-07-29

6.  Non-compaction is not a simple genetic disorder.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Cardiovasc J Afr       Date:  2014 Jan-Feb       Impact factor: 1.167

Review 7.  State-of-the art review: Noncompaction cardiomyopathy in pediatric patients.

Authors:  Sofie Rohde; Rahatullah Muslem; Emrah Kaya; Michel Dalinghaus; Jaap I van Waning; Danielle Majoor-Krakauer; Jeffery Towbin; Kadir Caliskan
Journal:  Heart Fail Rev       Date:  2021-03-14       Impact factor: 4.214

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.